Bernd Kühn

Title: Inventor Bernd Kühn: A Pioneer in Medicinal Solutions

Introduction

Bernd Kühn, an innovative inventor based in Köln, Germany, has made significant contributions to the field of medicinal solutions. With a total of two patents to his name, Kühn’s work primarily focuses on formulations that improve the effectiveness of treatments for bacterial infections in humans and animals. His dedication to innovation is evident in the unique methodologies and formulations he has developed throughout his career.

Latest Patents

Kühn’s latest patents are a testament to his expertise and innovative spirit. The first patent, titled "Moxifloxacin formulation containing common salt," involves an aqueous formulation that includes moxifloxacin hydrochloride and sodium chloride. This formulation is particularly promising for use as a medicament for preventing or treating bacterial infections. The second patent, "Method and device for in-situ formulation of a medicinal solution for parenteral application," outlines a method for creating a medicinal substance solution for parenteral administration. This method efficiently combines at least two metered part-streams using a mixer, resulting in a solution that is not in thermodynamic equilibrium, offering a novel approach to active ingredient administration.

Career Highlights

Bernd Kühn is affiliated with Bayer Aktiengesellschaft, a prominent company in the pharmaceutical sector. His role within Bayer has allowed him to collaborate on various innovative projects and contribute to the company’s commitment to advancing medical treatments. His inventions reflect not just a dedication to pharmacy but also an understanding of the complexities involved in developing effective medicinal solutions.

Collaborations

Throughout his career, Kühn has worked alongside esteemed colleagues such as Georg Wiessmeier and Roland Rupp. These collaborations have facilitated the exchange of ideas and expertise, further enhancing the scope of research and development in which they are involved. Working with such talented professionals has enriched Kühn’s own inventive process, leading to significant advancements in medicinal formulations.

Conclusion

Bernd Kühn stands out as a notable inventor within the pharmaceutical industry, with patents that showcase his commitment to improving health care solutions. His innovative formulations and methods demonstrate his vital role in the ongoing quest for effective treatments against bacterial infections. As he continues his work at Bayer Aktiengesellschaft, the impact of his inventions will undoubtedly contribute to advancements in medical science and patient care.